TGFB1 and myelodysplastic syndrome: Research from patients of low-risk MDS has found that bone marrow stromal cells and MDS clonal cells secrets excessive hematopoietic inhibitory factors like TNF-α, IFN-γ, TGF-β, and VEGF.